MedPath
NMPA Approval

Lornoxicam for Injection

国药准字H20249636

December 1, 2024

Drug Information

注射用氯诺昔康

注射剂

8mg

化学药品

December 1, 2024

Company Information

Applicant Company

湖北省武汉市东西湖区柏泉祁家山特1号

Manufacturing Company

湖北省武汉市东西湖区柏泉祁家山特1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用氯诺昔康 - NMPA 批准文号 | MedPath